<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        11-367-07
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2007
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        GLYPRESSIN 1MG POWDER FOR I.V. Injection*
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        TERLIPRESSIN DIACETATE PENTAHYDRATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        737.55
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="RENTSCHLER BIOTECHNOLOGIE" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            RENTSCHLER BIOTECHNOLOGIE
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 612]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Abdulrehman Algosaibi G.T.C.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            FERRING
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        H01BA04
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>GLYPRESSIN&reg; 0.1mg/ml solution for injection contains terlipressin, which is a synthetic pituitary hormone. (This hormone is usually produced by the<br />pituitary gland found in the brain). It will be given to you by injection into a vein. GLYPRESSIN&reg; 0.1mg/ml solution for injection is used for treatment of<br />bleeding from varices in the food pipe (bleeding oesophageal varices).<br />Esophageal varices are enlarged blood vessels, which may be formed in the food pipe during hepatic diseases. They may burst and bleed and thus cause a<br />life-threatening state. After injection into blood circulation, the active ingredient terlipressin is changed into lysine-vasopressin. This happens at the walls of<br />the blood vessels, which means narrowing of the blood vessels, which leads to reduction of blood flow and reduction of bleeding. The administration of<br />terlipressin is for emergency treatment in cases of acute bleeding from esophageal varices until endoscopic therapy is available (therapeutic measures done at<br />and by inspection of the food pipe). Afterwards, administration of terlipressin for the treatment of bleeding from esophageal varices is usually an adjuvant<br />therapy to the endoscopic stopping of bleeding. Terlipressin can also be used for reducing early secondary bleeding.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use GLYPRESSIN&reg; 0.1mg/ml solution for injection<br />- if you are allergic to terlipressin or any of the other ingredients of this medicine (listed in section 6);<br />- if you are pregnant;<br />-In case of septic shock combined with low heart function (a septic shock is a severe disease, which appears, if a severe infection causes low blood pressure<br />and reduced blood flow).</p><p>Warnings and precautions<br />Talk to your doctor or pharmacist before using GLYPRESSIN&reg; 0.1mg/ml solution for injection.<br />This medicinal product is administered to you if you have bleeding in your food pipe, which is in most cases life-threatening. It is therefore used under<br />continuous monitoring of your blood pressure, heart rate and fluid balance. Your doctor should give you the injection intravenously to avoid tissue damage<br />through dying cells (necrosis) at injection site. If you are able to then tell your doctor if you suffer from the conditions shown below.<br />Please inform your doctor, if you have any of the conditions below:<br />A severe infection, known as septic shock; bronchial asthma or other conditions that affect your breathing; uncontrolled high blood pressure, insufficient<br />blood circulation of the coronary vessels (e.g. angina), coronary insufficiency, previous heart attack (myocardial infarction) or advanced arterial calcification<br />(arteriosclerosis); seizures (convulsions); irregular heartbeats (cardiac arrhythmias) or a history of QT interval prolongation (disturbance of heart rhythm);<br />heart diseases; poor blood circulation to your brain (e.g. you have had a stroke) or to your limbs (peripheral vascular disease); impaired kidney function<br />(renal insufficiency); if you suffer from a disturbances in the level of salt (electrolytes) in your blood; if you suffer from a reduced amount of fluid in your<br />circulation or have already lost a large amount of blood; or if you are over the age of 70 years.<br />Children and adolescents<br />Because of limited experience, this medicine should not be used in children and adolescents.<br />Elderly<br />The dose for elderly is defined by the doctor.<br />Other medicines and GLYPRESSIN&reg; 0.1mg/ml solution for injection<br />Tell your doctor or pharmacist if you are taking/using, have recently taken/used or might take/use any other medicines.<br />Please inform your doctor immediately if you take any of the following medicines:<br />&bull; drugs that have an effect on your heart rate (e.g. beta-blockers, propofol or sufentanil);<br />&bull; drugs that can trigger irregular beating of the heart (arrhythmia) such as the following:<br />anti-arryhthmic drugs known as Class IA (quinidine, procainamide, disopyramide) and Class III (amiodarone, sotalol, ibutilide, dofetilide); erythromycin<br />(an antibiotic); antihistamines (mainly used to treat allergies but also found in certain cough and cold remedies); tricyclic antidepressants used to treat<br />depression; or medicines that may alter the level of salt or electrolytes in your blood, particularly diuretics (water tablets used to treat high blood pressure and<br />heart failure).<br />Pregnancy and breast-feeding<br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking<br />this medicine.<br />Pregnancy: GLYPRESSIN&reg; 0.1 mg/ml solution for injection must not be used during pregnancy.<br />Breast-feeding: It is not known if GLYPRESSIN&reg; 0.1 mg/ml solution for injection is present in breast milk, therefore the possible effects on your baby are<br />unknown. You should discuss the potential risk to your baby with your doctor. Ask your doctor or pharmacist for advice before taking any medicine.</p><p>Driving and using machines<br />No studies on the effects on ability to drive and use machines have been performed.<br />GLYPRESSIN&reg; 0.1mg/ml solution for injection contains sodium<br />8,5 ml of GLYPRESSIN&reg; 0.1mg/ml solution for injection contains 1,34 mmol (30,71 mg) sodium. Consider this, if you are on a low-sodium diet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine will always be given to you by a doctor into your vein. The doctor will decide the most appropriate dose for you and your heart and blood<br />circulation will be continuously monitored during the injection. Please ask your doctor for further information regarding its use.<br />The recommended dose is:<br />Unless otherwise prescribed, initially 1.7mg terlipressin is administered intravenously in adults. Additional usual doses between 0.85 and 1.7 mg may be<br />administered each 4 hours until the bleedings are under control within 24 hours. After the starting dose, it may be necessary to adjust the dose to your body<br />weight. The same applies if side effects occur.<br />Method of administration<br />GLYPRESSIN&reg; 0.1mg/ml solution for injection is administered intravenously (directly into blood circulation).<br />Use in the elderly<br />If you are over 70 years of age speak with your doctor before you receive GLYPRESSIN&reg; 0.1mg/ml solution for injection.<br />Use in patients with kidney problems<br />GLYPRESSIN&reg; 0.1mg/ml solution for injection should be used with caution in patients with long standing kidney failure.<br />Use in patients with liver problems<br />No dose adjustment is required in patients with liver failure.<br />Use in children and adolescents<br />GLYPRESSIN&reg; 0.1mg/ml solution for injection is not recommended for use in children and adolescents due to insufficient experience.<br />Duration of treatment<br />Treatment should not last longer than 2 &ndash; 3 days, depending on the course of your condition.<br />If you use more GLYPRESSIN&reg; 0.1 mg/ml solution for injection than you should<br />As this medicine is given by a healthcare professional, then it is unlikely you will be given more than the recommended dose. If you are given too much then<br />you may have a rapid increase in your blood pressure (this will be noticed during the continuous monitoring), especially if you already suffer with high blood<br />pressure. If this happens then you will be given another medicine called an alpha blocker (e.g. clonidine) to control your blood pressure.<br />If you experience lightheadedness, dizziness, or feeling faint, tell your doctor because these could be signs of a low heart rate. This can be treated with<br />another medicine called atropine.<br />If you forget to use GLYPRESSIN&reg; 0.1 mg/ml solution for injection<br />You will be given GLYPRESSIN&reg; 0.1 mg/ml solution for injection in hospital under the supervision of a doctor.<br />If you stop using GLYPRESSIN&reg; 0.1 mg/ml solution for injection<br />Your doctor will advise when it is time to stop receiving this medicine.<br />If you have any further questions on the use of this medicine, ask your doctor, nurse, or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />Common (affects 1 to 10 of 100 treated patients)<br />Sodium deficiency in blood (hyponatraemia); Headache; Too slow heart rate (bradycardia); Disordered action of the heart (arrhythmia); Signs of insufficient<br />blood circulation through coronary vessels in ECG/EKG; Peripheral narrowing of vessels (arms and legs); Peripheral reduced blood circulation (arms and<br />legs); High blood pressure (hypertension); Pallor of skin; Low blood pressure (hypotension); Cramp-like stomach pain; Nausea; Diarrhea; Cramp-like<br />abdominal pain (in women).<br />Uncommon (affects 1 to 10 of 1,000 treated patients):<br />Causing of seizure disorders; Racing heart (tachycardia), Special disorders of heart rate (atrial fibrillation, ventricular extrasystoles); Pain in the chest caused<br />by insufficient blood circulation of coronary vessels (angina pectoris); Heart attack (myocardial infarction); Overload of liquid with discharge of liquid out of<br />small lung vessels (pulmonary capillaries) into lung tissue; Special disorders of heart rhythm (torsades de pointes); Weakness of the heart (cardiac<br />insufficiency); Reduced blood circulation of stomach arteries (intestinal ischaemia); Slowdown of blood flow because of high oxygen extraction through<br />organs and bluish colouration of the skin and lips (peripheral cyanosis); Hot flushes; Difficulty in breathing; Painful breathing; Pain in the chest (thoracic<br />pain); Cramps of bronchial musculature (bronchial spasms); Respiratory insufficiency; Cessation of breathing; Vomiting; Inflammation of lymphatic vessels<br />(lymphangitis) seen as fine red streaks under your skin extending from the affected area to the armpit or groin and by fever, chills, headache, and muscle<br />pain; Tissue damage caused by dying of cells (necrosis) of the skin; Increased tension of the uterus (uterine hypertonus); Decreased blood flow in the uterus;<br />Tissue damage caused by dying of cells (necrosis) at injection site.<br />Rare (affects 1 to 10 of 10,000 treated patients): Difficulty in breathing&nbsp;(dyspnoea).<br />Very rare (affects less than 1 in 10,000 treated patients): Apoplexy.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children. Do not use the medicinal product after the expiry date, which is stated on the outer carton/container.<br />The expiry date refers to the last day of that month. Store in a refrigerator (2&deg;C &ndash; 8&deg;C). Keep the ampoules in the outer carton in order to protect from light.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures<br />will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active ingredient is: 1 ampoule with 8.5 ml of solution contains terlipressin acetate equivalent to 0.1 mg terlipressin/ml.<br />The other ingredients are: sodium chloride, acetic acid 99 %, sodium acetate trihydrate, water for injection.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                GLYPRESSIN® 0.1 mg/ml solution for injection is a clear, colourless solution.
GLYPRESSIN® 0.1 mg/ml solution for injection is available in packages of 5 ampoules each containing 8.5 ml of solution.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>FERRING GmbH, Wittland 11, D-24109 Kiel, Germany.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                April 2015.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="ltr">ﻳﺤﺘﻮﻱ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﻋﻠﻰ ﺗﻴﺮﻟﻴﺒﺮﻳﺴﲔ، ﻭﻫﻮ ﺃﺣﺪ ﻫﺮﻣﻮﻧﺎﺕ ﺍﻟﻐﺪﺓ ﺍﻟﻨﺨﺎﻣﻴﺔ ﺍﻟﺘﺨﻠﻴﻘﻴﺔ. )ﻳﻨﺘﺞ ﻫﺬﺍ ﺍﻟﻬﺮﻣﻮﻥ ﻋﺎﺩﺓ ﻋﻦ ﻃﺮﻳﻖ&nbsp;<br />ﺍﻟﻐﺪﺓ ﺍﻟﻨﺨﺎﻣﻴﺔ ﺍﳌﻮﺟﻮﺩﺓ ﻓﻲ ﺍﳌﺦ(. ﺳﻴﻌﻄﻰ ﻟﻚ ﻋﻦ ﻃﺮﻳﻖ ﺍﳊﻘﻦ ﻓﻲ ﺍﻟﻮﺭﻳﺪ.<br />ﻳﺴﺘﺨﺪﻡ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﻟﻌﻼﺝ ﺍﻟﻨﺰﻳﻒ ﺍﻟﻨﺎﺟﻢ ﻋﻦ ﺍﻟﺪﻭﺍﻟﻲ ﺍﻟﺘﻲ ﺗﺼﻴﺐ ﺍﳌﺮﻱﺀ )ﺩﻭﺍﻟﻲ ﺍﳌﺮﻱﺀ ﺍﻟﻨﺰﻓﻴﺔ(.<br />ﺩﻭﺍﻟﻲ ﺍﳌﺮﻱﺀ ﻫﻲ ﻋﺒﺎﺭﺓ ﻋﻦ ﺗﻮﺳﻊ ﻓﻲ ﺍﻷﻭﻋﻴﺔ ﺍﻟﺪﻣﻮﻳﺔ، ﻭﺍﻟﺘﻲ ﻗﺪ ﺗﺘﺸﻜﻞ ﻓﻲ ﺍﳌﺮﻱﺀ ﺃﺛﻨﺎﺀ ﺍﻹﺻﺎﺑﺔ ﺑﺄﻣﺮﺍﺽ ﺍﻟﻜﺒﺪ. ﻗﺪ ﺗﻨﻔﺠﺮ ﺍﻟﺪﻭﺍﻟﻲ ﻭﺗﻨﺰﻑ، ﻭﺑﺎﻟﺘﺎﻟﻲ ﺗﺘﺴﺒﺐ ﻓﻲ&nbsp;<br />ﺣﺪﻭﺙ ﺣﺎﻟﺔ ﻣﻬﺪﺩﺓ ﻟﻠﺤﻴﺎﺓ. ﺑﻌﺪ ﺍﳊﻘﻦ ﻓﻲ ﺍﻟﺪﻭﺭﺓ ﺍﻟﺪﻣﻮﻳﺔ، ﺗﺘﻐﻴﺮ ﺍﳌﺎﺩﺓ ﺍﻟﻔﻌﺎﻟﺔ ﺗﻴﺮﻟﻴﺒﺮﻳﺴﲔ ﺇﻟﻰ ﻻﻳﺴﲔ - ﻓﺎﺯﻭﺑﺮﻳﺴﲔ. ﻳﺤﺪﺙ ﻫﺬﺍ ﻋﻠﻰ ﺟﺪﺭﺍﻥ ﺍﻷﻭﻋﻴﺔ ﺍﻟﺪﻣﻮﻳﺔ،&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>٢ ﻣﺎ ﺍﻟﺬﻱ ﲢﺘﺎﺝ ﺇﻟﻰ ﻣﻌﺮﻓﺘﻪ ﻗﺒﻞ ﺍﺳﺘﺨﺪﺍﻡ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﻻ ﺗﺴﺘﺨﺪﻡ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﻓﻲ ﺍﳊﺎﻻﺕ ﺍﻵﺗﻴﺔ:</p><p>ﺇﺫﺍ ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﻣﻦ ﺣﺴﺎﺳﻴﺔ ﲡﺎﻩ ﺗﻴﺮﻟﻴﺒﺮﻳﺴﲔ ﺃﻭ ﲡﺎﻩ ﺃﻱ ﻣﻜﻮﻥ ﻣﻦ ﺍﳌﻜﻮﻧﺎﺕ ﺍﻷﺧﺮﻯ ﺑﻬﺬﺍ ﺍﻟﺪﻭﺍﺀ )ﺍﳌﺪﺭﺟﺔ ﻓﻲ ﻗﺴﻢ ٦(؛<br />ﺇﺫﺍ ﻛﻨﺖ ﺣﺎﻣﻼ؛<br />ﻓﻲ ﺣﺎﻝ ﺣﺪﻭﺙ ﺻﺪﻣﺔ ﺇﻧﺘﺎﻧﻴﺔ ﻣﺼﺎﺣﺒﺔ ﻟﻘﺼﻮﺭ ﺑﻮﻇﺎﺋﻒ ﺍﻟﻘﻠﺐ )ﺍﻟﺼﺪﻣﺔ ﺍﻹﻧﺘﺎﻧﻴﺔ ﻫﻲ ﻣﺮﺽ ﺷﺪﻳﺪ، ﻳﻈﻬﺮ ﺇﺫﺍ ﺗﺴﺒﺒﺖ ﺍﻟﻌﺪﻭﻯ ﺍﻟﺸﺪﻳﺪﺓ ﻓﻲ ﺍﻧﺨﻔﺎﺽ ﺿﻐﻂ ﺍﻟﺪﻡ&nbsp;</p><p>ﻭﺍﻧﺨﻔﺎﺽ ﺗﺪﻓﻖ ﺍﻟﺪﻡ</p><p>ﲢﺬﻳﺮﺍﺕ ﻭﺍﺣﺘﻴﺎﻃﺎﺕ<br />ﲢﺪﺙ ﺇﻟﻰ ﻃﺒﻴﺒﻚ ﺃﻭ ﺍﻟﺼﻴﺪﻟﻲ ﺍﳋﺎﺹ ﺑﻚ ﻗﺒﻞ ﺍﺳﺘﺨﺪﺍﻡ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ.</p><p>ﻳﺘﻢ ﺇﻋﻄﺎﺅﻙ ﻫﺬﺍ ﺍﳌﻨﺘﺞ ﺍﻟﺪﻭﺍﺋﻲ ﺇﺫﺍ ﻛﻨﺖ ﻣﺼﺎﺑﺎ ﺑﻨﺰﻳﻒ ﻓﻲ ﺍﳌﺮﻱﺀ ﻭﺍﻟﺬﻱ ﻳﻜﻮﻥ ﻓﻲ ﻏﺎﻟﺒﻴﺔ ﺍﳊﺎﻻﺕ ﻣﻬﺪﺩﺍ ﻟﻠﺤﻴﺎﺓ. ﻟﺬﺍ، ﻳﺴﺘﺨﺪﻡ ﻫﺬﺍ ﺍﻟﺪﻭﺍﺀ ﻓﻲ ﻇﻞ ﻣﺮﺍﻗﺒﺔ ﻣﺴﺘﻤﺮﺓ ﻟﻀﻐﻂ ﺍﻟﺪﻡ ﻭﻣﻌﺪﻝ ﺿﺮﺑﺎﺕ ﺍﻟﻘﻠﺐ ﻭﺗﻮﺍﺯﻥ ﺍﻟﺴﻮﺍﺋﻞ ﻟﺪﻳﻚ. ﻳﺠﺐ ﺃﻥ ﻳﻌﻄﻴﻚ ﻃﺒﻴﺒﻚ ﺍﳊﻘﻦ ﻋﻦ ﻃﺮﻳﻖ ﺍﻟﻮﺭﻳﺪ؛ ﻟﺘﺠﻨﺐ ﺣﺪﻭﺙ ﺗﻠﻒ ﺑﺎﻷﻧﺴﺠﺔ ﻣﻦ ﺧﻼﻝ ﺍﳋﻼﻳﺎ ﺍﳌﻴﺘﺔ )ﺍﻟﻨﺨﺮ( ﻓﻲ ﻣﻮﺿﻊ ﺍﳊﻘﻦ. ﺇﺫﺍ ﻛﻨﺖ ﻗﺎﺩﺭﺍ ﺑﻌﺪ ﺫﻟﻚ ﻓﺄﺧﺒﺮ ﻃﺒﻴﺒﻚ ﺇﺫﺍ ﻋﺎﻧﻴﺖ ﻣﻦ ﺍﳊﺎﻻﺕ ﺍﳌﻮﺿﺤﺔ ﺃﺩﻧﺎﻩ.<br />ﻳﺮﺟﻰ ﺇﺑﻼﻍ ﻃﺒﻴﺒﻚ ﺇﺫﺍ ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﻣﻦ ﺍﳊﺎﻻﺕ ﺍﻵﺗﻴﺔ:</p><p>ﻋﺪﻭﻯ ﺷﺪﻳﺪﺓ، ﺗﻌﺮﻑ ﺑﺎﺳﻢ ﺍﻟﺼﺪﻣﺔ ﺍﻹﻧﺘﺎﻧﻴﺔ؛ ﺭﺑﻮ ﺷﻌﺒﻲ ﺃﻭ ﺣﺎﻻﺕ ﺃﺧﺮﻯ ﺗﺆﺛﺮ ﻋﻠﻰ ﺗﻨﻔﺴﻚ؛ ﺍﺭﺗﻔﺎﻉ ﺿﻐﻂ ﺍﻟﺪﻡ ﻏﻴﺮ ﺍﳌﻨﻀﺒﻂ، ﻗﺼﻮﺭ ﻓﻲ ﺍﻟﺪﻭﺭﺓ ﺍﻟﺪﻣﻮﻳﺔ ﺑﺎﻷﻭﻋﻴﺔ ﺍﻟﺘﺎﺟﻴﺔ )ﻋﻠﻰ ﺳﺒﻴﻞ ﺍﳌﺜﺎﻝ: ﺍﻟﺬﺑﺤﺔ ﺍﻟﺼﺪﺭﻳﺔ(، ﻗﺼﻮﺭ ﻓﻲ ﺍﻟﺸﺮﻳﺎﻥ ﺍﻟﺘﺎﺟﻲ، ﻧﻮﺑﺔ ﻗﻠﺒﻴﺔ ﺳﺎﺑﻘﺔ )ﺍﺣﺘﺸﺎﺀ ﻋﻀﻠﺔ ﺍﻟﻘﻠﺐ( ﺃﻭ ﺗﻜﻠﺲ ﺷﺮﻳﺎﻧﻲ ﻣﺘﻘﺪﻡ )ﺗﺼﻠﺐ ﺍﻟﺸﺮﺍﻳﲔ(؛ﻧﻮﺑﺎﺕ ﺻﺮﻉ )ﺗﺸﻨﺠﺎﺕ(؛ ﻋﺪﻡ ﺍﻧﺘﻈﺎﻡ ﺿﺮﺑﺎﺕ ﺍﻟﻘﻠﺐ )ﺍﺿﻄﺮﺍﺑﺎﺕ ﺍﻟﻨﻈﻢ ﺍﻟﻘﻠﺒﻲ( ﺃﻭ ﺗﺎﺭﻳﺦ ﺳﺎﺑﻖ ﻣﻦ ﺇﻃﺎﻟﺔ ﻓﺘﺮﺓ &quot;) &quot;QTﺍﺿﻄﺮﺍﺏ ﻓﻲ ﺍﻟﻨﻈﻢ ﺍﻟﻘﻠﺒﻲ(؛ ﺃﻣﺮﺍﺽ ﺍﻟﻘﻠﺐ؛ﺿﻌﻒ ﺍﻟﺪﻭﺭﺓ ﺍﻟﺪﻣﻮﻳﺔ ﺇﻟﻰ ﺍﳌﺦ ﻟﺪﻳﻚ )ﻋﻠﻰ ﺳﺒﻴﻞ ﺍﳌﺜﺎﻝ: ﺇﺫﺍ ﻛﻨﺖ ﻗﺪ ﺃﺻﺒﺖ ﺑﺴﻜﺘﺔ ﺩﻣﺎﻏﻴﺔ( ﺃﻭ ﺇﻟﻰ ﺍﻷﻃﺮﺍﻑ )ﻣﺮﺽ ﻭﻋﺎﺋﻲ ﻃﺮﻓﻲ(؛ ﻗﺼﻮﺭ ﺑﻮﻇﺎﺋﻒ ﺍﻟﻜﻠﻰ؛ ﺇﺫﺍ ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﻣﻦ ﺍﺿﻄﺮﺍﺑﺎﺕ ﻓﻲ ﻣﺴﺘﻮﻯ ﺍﳌﻠﺢ )ﺍﻹﻟﻴﻜﺘﺮﻭﻟﻴﺘﺎﺕ( ﻟﺪﻳﻚ ﻓﻲ ﺍﻟﺪﻡ؛ ﺇﺫﺍ ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﻣﻦ ﺍﻧﺨﻔﺎﺽ ﻛﻤﻴﺔ ﺍﻟﺴﻮﺍﺋﻞ ﻓﻲ ﺩﻭﺭﺗﻚ ﺍﻟﺪﻣﻮﻳﺔ ﺃﻭ ﻓﻘﺪﺕ ﺑﺎﻟﻔﻌﻞ ﻛﻤﻴﺔ ﻛﺒﻴﺮﺓ ﻣﻦ ﺍﻟﺪﻡ؛ ﺇﺫﺍ ﻛﺎﻥ ﺳﻨﻚ ﻳﺰﻳﺪ ﻋﻦ ٠٧ ﻋﺎﻣﺎ.<br />ﺍﻷﻃﻔﺎﻝ ﻭﺍﳌﺮﺍﻫﻘﻮﻥ</p><p>ﻳﺠﺐ ﺃﻻ ﻳﺴﺘﺨﺪﻡ ﻫﺬﺍ ﺍﻟﻌﻘﺎﺭ ﻟﻸﻃﻔﺎﻝ ﻭﺍﳌﺮﺍﻫﻘﲔ، ﻧﻈﺮﺍ ﺇﻟﻰ ﻭﺟﻮﺩ ﺧﺒﺮﺓ ﻣﺤﺪﻭﺩﺓ. ﺍﳌﺮﺿﻰ ﻣﻦ ﻛﺒﺎﺭ ﺍﻟﺴﻦ</p><p>ﻳﺤﺪﺩ ﺍﻟﻄﺒﻴﺐ ﺍﳉﺮﻋﺔ ﻟﻠﻤﺮﺿﻰ ﻣﻦ ﻛﺒﺎﺭ ﺍﻟﺴﻦ.<br />ﺍﺳﺘﺨﺪﺍﻡ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﻣﻊ ﺃﺩﻭﻳﺔ ﺃﺧﺮﻯ</p><p>ﻳﺮﺟﻰ ﺇﺑﻼﻍ ﻃﺒﻴﺒﻚ ﺃﻭ ﺍﻟﺼﻴﺪﻟﻲ ﺍﳋﺎﺹ ﺑﻚ ﺇﺫﺍ ﻛﻨﺖ ﺗﺘﻨﺎﻭﻝ/ ﺗﺴﺘﺨﺪﻡ ﺃﻭ ﺗﻨﺎﻭﻟﺖ/ ﺍﺳﺘﺨﺪﻣﺖ ﻣﺆﺧﺮﺍ ﺃﻭ ﻗﺪ ﺗﺘﻨﺎﻭﻝ/ ﺗﺴﺘﺨﺪﻡ ﺃﻳﺔ ﺃﺩﻭﻳﺔ ﺃﺧﺮﻯ.</p><p>ﺃﺧﺒﺮ ﻃﺒﻴﺒﻚ ﻓﻮﺭﺍ، ﺇﺫﺍ ﻛﻨﺖ ﺗﺘﻨﺎﻭﻝ ﺃﻳﺎ ﻣﻦ ﺍﻷﺩﻭﻳﺔ ﺍﻟﺘﺎﻟﻴﺔ:<br />ﺍﻟﻌﻘﺎﻗﻴﺮ ﺫﺍﺕ ﺍﻟﺘﺄﺛﻴﺮ ﻋﻠﻰ ﻣﻌﺪﻝ ﺿﺮﺑﺎﺕ ﺍﻟﻘﻠﺐ ﻟﺪﻳﻚ )ﻋﻠﻰ ﺳﺒﻴﻞ ﺍﳌﺜﺎﻝ: ﺣﺎﺻﺮﺍﺕ ﺑﻴﺘﺎ ﺃﻭ ﺑﺮﻭﺑﻮﻓﻮﻝ ﺃﻭ ﺳﻮﻓﻴﻨﺘﺎﻧﻴﻞ</p><p>ﺍﻟﻌﻘﺎﻗﻴﺮ ﺍﻟﺘﻲ ﲢﻔﺰ ﻋﺪﻡ ﺍﻧﺘﻈﺎﻡ ﺿﺮﺑﺎﺕ ﺍﻟﻘﻠﺐ )ﺍﺿﻄﺮﺍﺑﺎﺕ ﺍﻟﻨﻈﻢ ﺍﻟﻘﻠﺒﻲ( ﻣﺜﻞ ﻣﺎ ﻳﻠﻲ:</p><p>&nbsp;</p><p>ﻣﻀﺎﺩﺍﺕ ﺍﺿﻄﺮﺍﺏ ﺍﻟﻨﻈﻢ ﺍﻟﻘﻠﺒﻲ ﻭﺍﻟﺘﻲ ﺗﻌﺮﻑ ﺑﻜﻮﻧﻬﺎ ﻣﻦ ﺍﻟﻔﺌﺔ ١ﺃ ﻛﻴﻨﻴﺪﻳﻦ، ﺑﺮﻭﻛﺎﻳﻨﺎﻣﻴﺪ، ﺩﻳﺴﻮﺑﻴﺮﺍﻣﻴﺪ( ﻭﺍﻟﻔﺌﺔ ٣ )ﺃﻣﻴﻮﺩﺍﺭﻭﻥ، ﺳﻮﺗﺎﻟﻮﻝ، ﺇﺑﻴﻮﺗﻴﻠﻴﺪ، ﺩﻭﻓﺘﻴﻠﻴﺪ(؛ ﺇﺭﻳﺜﺮﻭﻣﻴﺴﲔ )ﻣﻀﺎﺩ ﺣﻴﻮﻱ(؛ ﻣﻀﺎﺩﺍﺕ ﺍﻟﻬﻴﺴﺘﺎﻣﲔ )ﺗﺴﺘﺨﺪﻡ ﺑﺸﻜﻞ ﺃﺳﺎﺳﻲ ﻟﻌﻼﺝ ﺣﺎﻻﺕ ﺍﳊﺴﺎﺳﻴﺔ ﻭﻟﻜﻨﻬﺎ ﺃﻳﻀﺎ ﺗﻮﺟﺪ ﻓﻲ ﺑﻌﺾ ﻋﻼﺟﺎﺕ ﺍﻟﺴﻌﺎﻝ ﻭﺍﻟﺒﺮﺩ(؛ ﻣﻀﺎﺩﺍﺕ ﺍﻻﻛﺘﺌﺎﺏ ﺛﻼﺛﻴﺔ ﺍﳊﻠﻘﺎﺕ ﺍﻟﺘﻲ ﺗﺴﺘﺨﺪﻡ ﻓﻲ ﻋﻼﺝ ﺍﻻﻛﺘﺌﺎﺏ؛ ﺍﻷﺩﻭﻳﺔ ﺍﻟﺘﻲ ﻗﺪ ﺗﻐﻴﺮ ﻣﺴﺘﻮﻯ ﺍﳌﻠﺢ ﺃﻭ ﺍﻹﻟﻴﻜﺘﺮﻭﻟﻴﺘﺎﺕ ﻟﺪﻳﻚ ﻓﻲ ﺍﻟﺪﻡ، ﻻ ﺳﻴﻤﺎ ﻣﺪﺭﺍﺕ ﺍﻟﺒﻮﻝ )ﺃﻗﺮﺍﺹ ﺍﳌﺎﺀ ﺍﻟﺘﻲ ﺗﺴﺘﺨﺪﻡ ﻟﻌﻼﺝ ﺍﺭﺗﻔﺎﻉ ﺿﻐﻂ ﺍﻟﺪﻡ ﻭﻓﺸﻞ ﺍﻟﻘﻠﺐ(.<br />ﺍﳊﻤﻞ ﻭﺍﻟﺮﺿﺎﻋﺔ ﺍﻟﻄﺒﻴﻌﻴﺔ<br />ﺇﺫﺍ ﻛﻨﺖ ﺣﺎﻣﻼ ﺃﻭ ﻣﺮﺿﻌﺔ، ﺃﻭ ﺗﻌﺘﻘﺪﻳﻦ ﺃﻧﻚ ﺣﺎﻣﻞ ﺃﻭ ﺗﺨﻄﻄﲔ ﻟﺬﻟﻚ، ﻓﺎﺳﺘﺸﻴﺮﻱ ﻃﺒﻴﺒﻚ ﺃﻭ ﺍﻟﺼﻴﺪﻟﻲ ﺍﳋﺎﺹ ﺑﻚ ﻗﺒﻞ ﺍﺳﺘﺨﺪﺍﻡ ﻫﺬﺍ ﺍﻟﺪﻭﺍﺀ.<br />ﺍﳊﻤﻞ&nbsp;<br />ﻳﺠﺐ ﻋﺪﻡ ﺍﺳﺘﺨﺪﺍﻡ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﺃﺛﻨﺎﺀ ﺍﳊﻤﻞ.<br />ﺍﻟﺮﺿﺎﻋﺔ ﺍﻟﻄﺒﻴﻌﻴﺔ<br />ﻣﻦ ﻏﻴﺮ ﺍﳌﻌﺮﻭﻑ ﻣﺎ ﺇﺫﺍ ﻛﺎﻥ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﻳﻮﺟﺪ ﻓﻲ ﻟﱭ ﺍﻷﻡ ﺃﻡ ﻻ، ﻭﺑﺎﻟﺘﺎﻟﻲ ﻓﺈﻥ ﺍﻟﺘﺄﺛﻴﺮﺍﺕ ﺍﶈﺘﻤﻠﺔ ﻋﻠﻰ ﻃﻔﻠﻚ ﻏﻴﺮ ﻣﻌﺮﻭﻓﺔ. ﻳﺠﺐ ﻋﻠﻴﻚ ﻣﻨﺎﻗﺸﺔ ﺍﻟﻤﺨﺎﻃﺮ ﺍﶈﺘﻤﻞ ﺗﻌﺮﺽ ﻃﻔﻠﻚ ﻟﻬﺎ ﻣﻊ ﻃﺒﻴﺒﻚ. ﺍﺳﺘﺸﻴﺮﻱ ﻃﺒﻴﺒﻚ ﺃﻭ ﺍﻟﺼﻴﺪﻟﻲ ﺍﳋﺎﺹ ﺑﻚ ﻗﺒﻞ ﺗﻨﺎﻭﻝ ﺃﻱ ﺩﻭﺍﺀ.<br />ﺍﻟﻘﻴﺎﺩﺓ ﻭﺍﺳﺘﺨﺪﺍﻡ ﺍﻵﻻﺕ<br />ﻟﻢ ﻳﺘﻢ ﺇﺟﺮﺍﺀ ﺃﻳﺔ ﺩﺭﺍﺳﺎﺕ ﺑﺸﺄﻥ ﺍﻟﺘﺄﺛﻴﺮﺍﺕ ﻋﻠﻰ ﺍﻟﻘﺪﺭﺓ ﻋﻠﻰ ﺍﻟﻘﻴﺎﺩﺓ ﻭﺍﺳﺘﺨﺪﺍﻡ ﺍﻵﻻﺕ.<br />ﻳﺤﺘﻮﻱ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﻋﻠﻰ ﺍﻟﺼﻮﺩﻳﻮﻡ<br />ﻳﺤﺘﻮﻱ ﻛﻞ ٥٫٨ ﻣﻞ ﻣﻦ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﻋﻠﻰ١٫٣٤ &nbsp;ﻣﻠﻠﻲ ﻣﻮﻝ )٣٠٫٧١ ﻣﻠﻐﻢ( ﺻﻮﺩﻳﻮﻡ. ﺿﻊ ﺫﻟﻚ ﻓﻲ ﺍﻋﺘﺒﺎﺭﻙ، ﺇﺫﺍ ﻛﻨﺖ ﺗﺘﺒﻊ ﻧﻈﺎﻣﺎ ﻏﺬﺍﺋﻴﺎ ﻣﻨﺨﻔﺾ ﺍﻟﺼﻮﺩﻳﻮﻡ.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>ﺳﻴﺘﻮﻟﻰ ﺍﻟﻄﺒﻴﺐ ﺩﺍﺋﻤﺎ ﺇﻋﻄﺎﺀﻙ ﻫﺬﺍ ﺍﻟﺪﻭﺍﺀ ﻓﻲ ﺍﻟﻮﺭﻳﺪ. ﺳﻴﻘﺮﺭ ﺍﻟﻄﺒﻴﺐ ﺍﳉﺮﻋﺔ ﺍﻷﻧﺴﺐ ﺑﺎﻟﻨﺴﺒﺔ ﻟﻚ ﻭﺳﺘﺘﻢ ﻣﺮﺍﻗﺒﺔ ﻗﻠﺒﻚ ﻭﺩﻭﺭﺗﻚ ﺍﻟﺪﻣﻮﻳﺔ ﺑﺎﺳﺘﻤﺮﺍﺭ ﺃﺛﻨﺎﺀ ﺍﳊﻘﻦ. ﺭﺟﺎﺀ ﺍﻃﻠﺐ ﻣﻦ ﻃﺒﻴﺒﻚ ﻣﺰﻳﺪﺍ ﻣﻦ ﺍﳌﻌﻠﻮﻣﺎﺕ ﺑﺸﺄﻥ ﺍﺳﺘﺨﺪﺍﻡ ﺍﻟﻌﻘﺎﺭ.<br />ﺍﳉﺮﻋﺔ ﺍﳌﻮﺻﻰ ﺑﻬﺎ ﻫﻲ:</strong></p><p><strong>ﻣﺎ ﻟﻢ ﻳﻮﺻﻒ ﺧﻼﻑ ﺫﻟﻚ، ﻳﺘﻢ ﺇﻋﻄﺎﺀ ٧٫١ ﻣﻠﻐﻢ ﻣﻦ ﺗﻴﺮﻟﻴﺒﺮﻳﺴﲔ ﻓﻲ ﺍﻟﺒﺪﺍﻳﺔ ﻋﻦ ﻃﺮﻳﻖ ﺍﻟﻮﺭﻳﺪ ﻓﻲ ﺍﻟﺒﺎﻟﻐﲔ. ﻗﺪ ﻳﺘﻢ ﺇﻋﻄﺎﺀ ﺟﺮﻋﺎﺕ ﺇﺿﺎﻓﻴﺔ ﻣﻌﺘﺎﺩﺓ ﺗﺘﺮﺍﻭﺡ ﺑﲔ٠٫٨٥ &nbsp;ﻭ١٫٧ ﻣﻠﻐﻢ ﻛﻞ ٤ ﺳﺎﻋﺎﺕ ﺣﺘﻰ ﻳﺼﺒﺢ ﺍﻟﻨﺰﻳﻒ ﲢﺖ ﺍﻟﺴﻴﻄﺮﺓ ﻓﻲ ﻏﻀﻮﻥ ٤٢ ﺳﺎﻋﺔ. ﺑﻌﺪ ﺇﻋﻄﺎﺀ ﺟﺮﻋﺔ ﺍﻟﺒﺪﺀ ﻗﺪ ﻳﻜﻮﻥ ﻣﻦ ﺍﻟﻀﺮﻭﺭﻱ ﺗﻌﺪﻳﻞ ﺍﳉﺮﻋﺔ ﺣﺴﺐ ﻭﺯﻥ ﺟﺴﻤﻚ. ﻳﻨﻄﺒﻖ ﺍﻷﻣﺮ ﻧﻔﺴﻪ ﺇﺫﺍ ﺣﺪﺛﺖ ﺁﺛﺎﺭ ﺟﺎﻧﺒﻴﺔ.<br />ﻃﺮﻳﻘﺔ ﺍﻹﻋﻄﺎﺀ</strong></p><p><strong>ﻳﺴﺘﺨﺪﻡ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﻋﻦ ﻃﺮﻳﻖ ﺍﻟﻮﺭﻳﺪ )ﻓﻲ ﺍﻟﺪﻭﺭﺓ ﺍﻟﺪﻣﻮﻳﺔ ﻣﺒﺎﺷﺮﺓ(.<br />ﺍﻻﺳﺘﺨﺪﺍﻡ ﻓﻲ ﻛﺒﺎﺭ ﺍﻟﺴﻦ<br />ﺇﺫﺍ ﻛﺎﻥ ﺳﻨﻚ ﻳﺰﻳﺪ ﻋﻦ ٠٧ ﻋﺎﻣﺎ، ﻓﺘﺤﺪﺙ ﻣﻊ ﻃﺒﻴﺒﻚ ﻗﺒﻞ ﺗﻠﻘﻲ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ. ﺍﻻﺳﺘﺨﺪﺍﻡ ﻓﻲ ﺍﳌﺮﺿﻰ ﺍﳌﺼﺎﺑﲔ ﲟﺸﺎﻛﻞ ﻓﻲ ﺍﻟﻜﻠﻰ<br />ﻳﺠﺐ ﺍﺳﺘﺨﺪﺍﻡ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﺑﺤﺬﺭ ﻓﻲ ﺍﳌﺮﺿﻰ ﺍﳌﺼﺎﺑﲔ ﺑﻔﺸﻞ ﻛﻠﻮﻱ ﻣﻨﺬ ﻓﺘﺮﺓ ﻃﻮﻳﻠﺔ. ﺍﻻﺳﺘﺨﺪﺍﻡ ﻓﻲ ﺍﳌﺮﺿﻰ ﺍﳌﺼﺎﺑﲔ ﲟﺸﺎﻛﻞ ﻓﻲ ﺍﻟﻜﺒﺪ<br />ﻻ ﻳﺴﺘﻠﺰﻡ ﺍﻷﻣﺮ ﺗﻌﺪﻳﻞ ﺍﳉﺮﻋﺔ ﻓﻲ ﺍﳌﺮﺿﻰ ﺍﳌﺼﺎﺑﲔ ﺑﻔﺸﻞ ﺍﻟﻜﺒﺪ.<br />ﺍﻻﺳﺘﺨﺪﺍﻡ ﻓﻲ ﺍﻷﻃﻔﺎﻝ ﻭﺍﳌﺮﺍﻫﻘﲔ<br />ﻻ ﻳﻮﺻﻰ ﺑﺎﺳﺘﺨﺪﺍﻡ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﻓﻲ ﺍﻷﻃﻔﺎﻝ ﻭﺍﳌﺮﺍﻫﻘﲔ ﻟﻌﺪﻡ ﻭﺟﻮﺩ ﺧﺒﺮﺓ ﻛﺎﻓﻴﺔ. ﻣﺪﺓ ﺍﻟﻌﻼﺝ<br />ﻳﺠﺐ ﺃﻻ ﻳﺴﺘﻤﺮ ﺍﻟﻌﻼﺝ ﻷﻛﺜﺮ ﻣﻦ ٢ -٣ ﺃﻳﺎﻡ، ﻭﻓﻘﺎ ﳌﺴﺎﺭ ﺣﺎﻟﺘﻚ.<br />ﺇﺫﺍ ﺍﺳﺘﺨﺪﻣﺖ ﻛﻤﻴﺔ ﺃﻛﺜﺮ ﳑﺎ ﻳﺠﺐ ﻣﻦ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ&nbsp;</strong></p><p><strong>ﻧﻈﺮﺍ ﺇﻟﻰ ﺃﻥ ﻫﺬﺍ ﺍﻟﺪﻭﺍﺀ ﻳﻌﻄﻴﻪ ﺃﺣﺪ ﺃﺧﺼﺎﺋﻴﻲ ﺍﻟﺮﻋﺎﻳﺔ ﺍﻟﺼﺤﻴﺔ، ﻓﻤﻦ ﻏﻴﺮ ﺍﶈﺘﻤﻞ ﺃﻥ ﻳﺘﻢ ﺇﻋﻄﺎﺅﻙ ﺃﻛﺜﺮ ﻣﻦ ﺍﳉﺮﻋﺔ ﺍﳌﻮﺻﻰ ﺑﻬﺎ. ﺇﺫﺍ ﰎ ﺇﻋﻄﺎﺅﻙ ﻛﻤﻴﺔ ﺃﻛﺜﺮ ﳑﺎ ﻳﺠﺐ ﻓﻘﺪ ﺗﺘﻌﺮﺽ ﻟﺰﻳﺎﺩﺓ ﺳﺮﻳﻌﺔ ﻓﻲ ﺿﻐﻂ ﺍﻟﺪﻡ )ﺳﻴﻼﺣﻆ ﺫﻟﻚ ﺃﺛﻨﺎﺀ ﺇﺟﺮﺍﺀ ﺍﳌﺮﺍﻗﺒﺔ ﺍﳌﺴﺘﻤﺮﺓ(، ﻻ ﺳﻴﻤﺎ ﺇﺫﺍ ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﺑﺎﻷﺳﺎﺱ ﻣﻦ ﺍﺭﺗﻔﺎﻉ ﺿﻐﻂ ﺍﻟﺪﻡ. ﺇﺫﺍ ﺣﺪﺙ ﺫﻟﻚ، ﻓﺴﻴﺘﻢ&nbsp;<br />ﺇﻋﻄﺎﺅﻙ ﺩﻭﺍﺀ ﺁﺧﺮ ﻳﺴﻤﻰ ﺣﺎﺻﺮ ﺃﻟﻔﺎ ﻋﻠﻰ ﺳﺒﻴﻞ ﺍﳌﺜﺎﻝ: ﻛﻠﻮﻧﻴﺪﻳﻦ( ﻟﻠﺘﺤﻜﻢ ﻓﻲ ﺿﻐﻂ ﺍﻟﺪﻡ ﻟﺪﻳﻚ &nbsp;.ﺇﺫﺍ ﺷﻌﺮﺕ ﺑﺪﻭﺍﺭ ﺑﺎﻟﺮﺃﺱ ﺃﻭ ﺩﻭﺧﺔ ﺃﻭ ﺷﻌﺮﺕ ﺑﺈﻏﻤﺎﺀ، ﻓﺄﺧﺒﺮ ﻃﺒﻴﺒﻚ؛ ﻷﻥ ﻫﺬﻩ ﻗﺪ ﺗﻜﻮﻥ ﻋﻼﻣﺎﺕ ﻋﻠﻰ ﺗﻌﺮﺿﻚ ﻻﻧﺨﻔﺎﺽ ﻣﻌﺪﻝ ﺿﺮﺑﺎﺕ ﺍﻟﻘﻠﺐ. ﳝﻜﻦ ﻋﻼﺝ ﺫﻟﻚ ﺑﺎﺳﺘﺨﺪﺍﻡ ﺩﻭﺍﺀ ﺁﺧﺮ ﻳﺴﻤﻰ ﺃﺗﺮﻭﺑﲔ.<br />ﺇﺫﺍ ﺃﻏﻔﻠﺖ ﺍﺳﺘﺨﺪﺍﻡ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ&nbsp;<br />ﺳﻴﺘﻢ ﺇﻋﻄﺎﺅﻙ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﻓﻲ ﺍﳌﺴﺘﺸﻔﻰ ﲢﺖ ﺇﺷﺮﺍﻑ ﺍﻟﻄﺒﻴﺐ.<br />ﺇﺫﺍ ﺗﻮﻗﻔﺖ ﻋﻦ ﺍﺳﺘﺨﺪﺍﻡ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ<br />ﺳﻴﻨﺼﻨﺤﻚ ﻃﺒﻴﺒﻚ ﲟﻮﻋﺪ ﺍﻟﺘﻮﻗﻒ ﻋﻦ ﺗﻠﻘﻲ ﻫﺬﺍ ﺍﻟﺪﻭﺍﺀ.&nbsp;<br />ﺇﺫﺍ ﻛﺎﻧﺖ ﻟﺪﻳﻚ ﺃﻳﺔ ﺃﺳﺌﻠﺔ ﺇﺿﺎﻓﻴﺔ ﺣﻮﻝ ﺍﺳﺘﺨﺪﺍﻡ ﻫﺬﺍ ﺍﻟﺪﻭﺍﺀ، ﻓﺎﺳﺘﺸﺮ ﻃﺒﻴﺒﻚ ﺃﻭ ﺍﳌﻤﺮﺽ)ﺓ( ﺃﻭ ﺍﻟﺼﻴﺪﻟﻲ ﺍﳋﺎﺹ ﺑﻚ.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>ﻣﺜﻠﻪ ﻣﺜﻞ ﻛﺎﻓﺔ ﺍﻷﺩﻭﻳﺔ، ﻗﺪ ﻳﺴﺒﺐ ﻫﺬﺍ ﺍﻟﺪﻭﺍﺀ ﺁﺛﺎﺭﺍ ﺟﺎﻧﺒﻴﺔ، ﻋﻠﻰ ﺍﻟﺮﻏﻢ ﻣﻦ ﻋﺪﻡ ﺣﺪﻭﺛﻬﺎ ﻟﺪﻯ ﺍﳉﻤﻴﻊ. ﺷﺎﺋﻌﺔ: )ﺗﺆﺛﺮ ﻋﻠﻰ ١ ﺇﻟﻰ ٠١ ﻣﻦ ﻛﻞ ٠٠١ ﻣﺮﻳﺾ ﻣﻌﺎﻟﺞ:</p><p>ﻧﻘﺺ ﺍﻟﺼﻮﺩﻳﻮﻡ ﺑﺎﻟﺪﻡ؛ ﺻﺪﺍﻉ؛ ﺑﻂﺀ ﺷﺪﻳﺪ ﲟﻌﺪﻝ ﺿﺮﺑﺎﺕ ﺍﻟﻘﻠﺐ؛ ﺍﺿﻄﺮﺍﺏ ﻋﻤﻞ ﺍﻟﻘﻠﺐ )ﺍﺿﻄﺮﺍﺑﺎﺕ ﺍﻟﻨﻈﻢ ﺍﻟﻘﻠﺒﻲ(؛ ﻇﻬﻮﺭ ﻋﻼﻣﺎﺕ ﺍﻹﺻﺎﺑﺔ ﺑﻘﺼﻮﺭ ﺍﻟﺪﻭﺭﺓ ﺍﻟﺪﻣﻮﻳﺔ ﺧﻼﻝ ﺍﻷﻭﻋﻴﺔ ﺍﻟﺘﺎﺟﻴﺔ ﻓﻲ ﺭﺳﻢ ﺍﻟﻘﻠﺐ ﺍﻟﻜﻬﺮﺑﺎﺋﻲ؛ ﺗﻀﻴﻖ ﺍﻷﻭﻋﻴﺔ ﺍﻟﺪﻣﻮﻳﺔ ﺍﻟﻄﺮﻓﻴﺔ )ﺍﻟﺬﺭﺍﻋﲔ ﻭﺍﻟﺴﺎﻗﲔ(؛ ﻗﺼﻮﺭ ﺍﻟﺪﻭﺭﺓ ﺍﻟﺪﻣﻮﻳﺔ ﺍﻟﻄﺮﻓﻴﺔ )ﺍﻟﺬﺭﺍﻋﲔ ﻭﺍﻟﺴﺎﻗﲔ(؛ ﺍﺭﺗﻔﺎﻉ ﺿﻐﻂ ﺍﻟﺪﻡ؛ ﺷﺤﻮﺏ ﺍﳉﻠﺪ؛ ﺍﻧﺨﻔﺎﺽ ﺿﻐﻂ ﺍﻟﺪﻡ؛ ﺃﻟﻢ ﻓﻲ ﺍﳌﻌﺪﺓ ﻳﺸﺒﻪ ﺍﻟﺘﻘﻠﺺ؛ ﻏﺜﻴﺎﻥ؛ ﺇﺳﻬﺎﻝ؛ ﺃﻟﻢ ﻓﻲ ﺍﻟﺒﻄﻦ ﻳﺸﺒﻪ ﺍﻟﺘﻘﻠﺺ )ﻓﻲ ﺍﻟﺴﻴﺪﺍﺕ(.<br />ﻏﻴﺮ ﺷﺎﺋﻌﺔ )ﺗﺆﺛﺮ ﻋﻠﻰ ١ ﺇﻟﻰ ٠١ ﻣﻦ ﻛﻞ١٫٠٠٠ &nbsp;ﻣﺮﻳﺾ ﻣﻌﺎﻟﺞ(:<br />ﺍﻟﺘﺴﺒﺐ ﻓﻲ ﺣﺪﻭﺙ ﺍﺿﻄﺮﺍﺑﺎﺕ ﺗﺸﻨﺠﻴﺔ؛ ﺗﺴﺎﺭﻉ ﺿﺮﺑﺎﺕ ﺍﻟﻘﻠﺐ؛ ﺍﺿﻄﺮﺍﺑﺎﺕ ﺧﺎﺻﺔ ﲟﻌﺪﻝ ﺿﺮﺑﺎﺕ ﺍﻟﻘﻠﺐ )ﺭﺟﻔﺎﻥ ﺃﺫﻳﻨﻲ، ﺍﻧﻘﺒﺎﺿﺎﺕ ﺑﻄﻴﻨﻴﺔ ﺧﺎﺭﺟﺔ(؛ ﺃﻟﻢ ﻓﻲ ﺍﻟﺼﺪﺭ ﻧﺎﺟﻢ ﻋﻦ ﻗﺼﻮﺭ ﺍﻟﺪﻭﺭﺓ ﺍﻟﺪﻣﻮﻳﺔ ﺑﺎﻷﻭﻋﻴﺔ ﺍﻟﺘﺎﺟﻴﺔ )ﺫﺑﺤﺔ ﺻﺪﺭﻳﺔ(؛ ﻧﻮﺑﺔ ﻗﻠﺒﻴﺔ )ﺍﺣﺘﺸﺎﺀ ﻋﻀﻠﺔ ﺍﻟﻘﻠﺐ(؛ ﻓﺮﻁ ﺍﻟﺘﺤﻤﻴﻞ ﺑﺎﻟﺴﻮﺍﺋﻞ ﻣﻊ ﺇﻓﺮﺍﺯ ﺳﻮﺍﺋﻞ ﻣﻦ ﺍﻷﻭﻋﻴﺔ ﺍﻟﺪﻗﻴﻘﺔ&nbsp;<br />ﺑﺎﻟﺮﺋﺔ )ﺷﻌﻴﺮﺍﺕ ﺩﻣﻮﻳﺔ ﺭﺋﻮﻳﺔ( ﻓﻲ ﻧﺴﻴﺞ ﺍﻟﺮﺋﺔ؛ ﺍﺿﻄﺮﺍﺑﺎﺕ ﺧﺎﺻﺔ ﺑﺎﻟﻨﻈﻢ ﺍﻟﻘﻠﺒﻲ )ﺍﻟﺘﻔﺎﻑ ﺍﻟﻨﻘﺎﻁ ]ﺇﺣﺪﻯ ﺍﻟﻌﻼﻣﺎﺕ ﺑﺮﺳﻢ ﺍﻟﻘﻠﺐ[(؛ ﺿﻌﻒ ﺍﻟﻘﻠﺐ )ﻗﺼﻮﺭ ﺑﻮﻇﺎﺋﻒ&nbsp;<br />ﺍﻟﻘﻠﺐ(؛ ﻗﺼﻮﺭ ﺍﻟﺪﻭﺭﺓ ﺍﻟﺪﻣﻮﻳﺔ ﺑﺸﺮﺍﻳﲔ ﺍﳌﻌﺪﺓ )ﺇﻗﻔﺎﺭ ﻣﻌﻮﻱ(؛ ﺗﺒﺎﻃﺆ ﺗﺪﻓﻖ ﺍﻟﺪﻡ ﺑﺴﺒﺐ ﺍﺭﺗﻔﺎﻉ ﻧﺴﺒﺔ ﻣﺎ ﺗﺴﺘﺨﻠﺼﻪ ﺍﻷﻋﻀﺎﺀ ﻣﻦ ﺍﻷﻛﺴﺠﲔ ﻭﺗﻐﻴﺮ ﻟﻮﻥ ﺍﳉﻠﺪ ﻭﺍﻟﺸﻔﺘﲔ ﺇﻟﻰ ﻟﻮﻥ ﻣﺎﺋﻞ ﺇﻟﻰ ﺍﻷﺯﺭﻕ )ﺯﺭﻗﺔ ﻃﺮﻓﻴﺔ(؛ ﻫﺒﺎﺕ ﺳﺎﺧﻨﺔ؛ ﺻﻌﻮﺑﺔ ﻓﻲ ﺍﻟﺘﻨﻔﺲ؛ ﺃﻟﻢ ﻋﻨﺪ ﺍﻟﺘﻨﻔﺲ؛ ﺃﻟﻢ ﻓﻲ ﺍﻟﺼﺪﺭ؛ ﺗﻘﻠﺼﺎﺕ ﻓﻲ ﻋﻀﻼﺕ ﺍﻟﺸﻌﺐ ﺍﻟﻬﻮﺍﺋﻴﺔ )ﺗﺸﻨﺠﺎﺕ&nbsp;<br />ﺷﻌﺒﻴﺔ(؛ ﻗﺼﻮﺭ ﻭﻇﺎﺋﻒ ﺍﳉﻬﺎﺯ ﺍﻟﺘﻨﻔﺴﻲ؛ ﺗﻮﻗﻒ ﺍﻟﺘﻨﻔﺲ؛ ﻗﻲﺀ؛ ﺍﻟﺘﻬﺎﺏ ﺍﻷﻭﻋﻴﺔ ﺍﻟﻠﻴﻤﻔﺎﻭﻳﺔ ﻋﻠﻰ ﻫﻴﺌﺔ ﺧﻄﻮﻁ ﺣﻤﺮﺍﺀ ﺭﻗﻴﻘﺔ ﲢﺖ ﺍﳉﻠﺪ ﲤﺘﺪ ﻣﻦ ﺍﳌﻨﻄﻘﺔ ﺍﳌﺼﺎﺑﺔ ﺇﻟﻰ ﺍﻹﺑﻂ ﺃﻭ ﺍﻷﺭﺑﻴﺔ ﻭﻳﺼﺤﺒﻪ ﺣﻤﻰ ﻭﻗﺸﻌﺮﻳﺮﺓ ﻭﺻﺪﺍﻉ ﻭﺃﻟﻢ ﻋﻀﻠﻲ؛ ﺗﻠﻒ ﺑﺎﻷﻧﺴﺠﺔ ﻧﺎﺟﻢ ﻋﻦ ﻣﻮﺕ ﺍﳋﻼﻳﺎ )ﺍﻟﻨﺨﺮ( ﺑﺎﳉﻠﺪ؛ ﺯﻳﺎﺩﺓ ﺗﻮﺗﺮ ﺍﻟﺮ ﺣﻢ )ﻓﺮﻁ ﺗﻮﺗﺮ ﺍﻟﺮﺣﻢ(؛ ﺍﻧﺨﻔﺎﺽ&nbsp;</p><p>ﺗﺪﻓﻖ ﺍﻟﺪﻡ ﻓﻲ ﺍﻟﺮﺣﻢ؛ ﺗﻠﻒ ﺑﺎﻷﻧﺴﺠﺔ ﻧﺎﺟﻢ ﻋﻦ ﻣﻮﺕ ﺍﳋﻼﻳﺎ )ﺍﻟﻨﺨﺮ( ﻓﻲ ﻣﻮﺿﻊ ﺍﳊﻘﻦ.<br />ﻧﺎﺩﺭﺓ )ﺗﺆﺛﺮ ﻋﻠﻰ ١ ﺇﻟﻰ ٠١ ﻣﻦ ﻛﻞ١٠٫٠٠٠ &nbsp;ﻣﺮﻳﺾ ﻣﻌﺎﻟﺞ(: ﺻﻌﻮﺑﺔ ﻓﻲ ﺍﻟﺘﻨﻔﺲ )ﺿﻴﻖ ﺍﻟﺘﻨﻔﺲ(.</p><p>ﻧﺎﺩﺭﺓ ﺟﺪﺍ ﺗﺆﺛﺮ ﻋﻠﻰ ﺃﻗﻞ ﻣﻦ ﻭﺍﺣﺪ ﻣﻦ ﻛﻞ١٠٫٠٠٠ &nbsp;ﻣﺮﻳﺾ ﻣﻌﺎﻟﺞ(: ﺳﻜﺘﺔ ﺩﻣﺎﻏﻴﺔ.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ﻳﺤﻔﻆ ﺑﻌﻴﺪﺍ ﻋﻦ ﻣﺘﻨﺎﻭﻝ ﻭﺭﺅﻳﺔ ﺍﻷﻃﻔﺎﻝ. ﻻ ﻳﺴﺘﺨﺪﻡ ﻫﺬﺍ ﺍﳌﻨﺘﺞ ﺍﻟﺪﻭﺍﺋﻲ ﺑﻌﺪ ﺍﻧﺘﻬﺎﺀ ﺗﺎﺭﻳﺦ ﺍﻟﺼﻼﺣﻴﺔ ﺍﳌﺪﻭﻥ ﻋﻠﻰ ﺍﻟﻌﺒﻮﺓ/ ﺍﻟﻌﺒﻮﺓ ﺍﻟﻜﺮﺗﻮﻧﻴﺔ ﺍﳋﺎﺭﺟﻴﺔ. ﻳﺸﻴﺮ ﺗﺎﺭﻳﺦ ﺍﻧﺘﻬﺎﺀ ﺍﻟﺼﻼﺣﻴﺔ ﺇﻟﻰ ﺍﻟﻴﻮﻡ ﺍﻷﺧﻴﺮ ﻣﻦ ﺫﻟﻚ ﺍﻟﺸﻬﺮ. ﻳﺤﻔﻆ ﻓﻲ ﺍﻟﺜﻼﺟﺔ )ﻋﻨﺪ ٢-٨ ﺩﺭﺟﺔ ﻣﺌﻮﻳﺔ(. ﺍﺣﺘﻔﻆ ﺑﺎﻷﻣﺒﻮﻻﺕ ﺩﺍﺧﻞ ﺍﻟﻌﺒﻮﺓ ﺍﻟﻜﺮﺗﻮﻧﻴﺔ ﺍﳋﺎﺭﺟﻴﺔ ﳊﻤﺎﻳﺘﻬﺎ ﻣﻦ ﺍﻟﻀﻮﺀ.&nbsp;</p><p>ﻻ ﺗﺘﺨﻠﺺ ﻣﻦ ﺍﻷﺩﻭﻳﺔ ﻋﻦ ﻃﺮﻳﻖ ﺇﻟﻘﺎﺋﻬﺎ ﻓﻲ ﻣﻴﺎﻩ ﺍﻟﺼﺮﻑ ﺃﻭ ﻣﻊ ﺍﻟﻤﺨﻠﻔﺎﺕ ﺍﳌﻨﺰﻟﻴﺔ. ﺍﺳﺘﺸﺮ ﺍﻟﺼﻴﺪﻟﻲ ﺍﳋﺎﺹ ﺑﻚ ﻋﻦ ﻛﻴﻔﻴﺔ ﺍﻟﺘﺨﻠﺺ ﻣﻦ ﺍﻷﺩﻭﻳﺔ ﺍﻟﺘﻲ ﻟﻢ ﺗﻌﺪ&nbsp;ﺗﺴﺘﺨﺪﻣﻬﺎ. ﺳﻮﻑ ﺗﺴﺎﻋﺪ ﻫﺬﻩ ﺍﻹﺟﺮﺍﺀﺍﺕ ﻓﻲ ﺍﳊﻔﺎﻅ ﻋﻠﻰ ﺍﻟﺒﻴﺌﺔ.<br />&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ﻣﺎ ﻫﻲ ﻣﺤﺘﻮﻳﺎﺕ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ</p><p>ﺍﳌﺎﺩﺓ ﺍﻟﻔﻌﺎﻟﺔ ﻫﻲ: ﺃﻣﺒﻮﻝ ﺑﻪ ٥٫٨ ﻣﻞ ﻣﻦ ﺍﶈﻠﻮﻝ ﺍﻟﺬﻱ ﻳﺤﺘﻮﻱ ﻋﻠﻰ ﺃﺳﻴﺘﺎﺕ ﺗﻴﺮﻟﻴﺒﺮﻳﺴﲔ ﲟﺎ ﻳﻌﺎﺩﻝ ١٫٠ ﻣﻠﻐﻢ ﺗﻴﺮﻟﻴﺒﺮﻳﺴﲔ/ ﻣﻞ. ﺍﳌﻜﻮﻧﺎﺕ ﺍﻷﺧﺮﻯ ﻫﻲ: ﻛﻠﻮﺭﻳﺪ ﺍﻟﺼﻮﺩﻳﻮﻡ، ﺣﻤﺾ ﺍﳋﻠﻴﻚ ٩٩٪، ﺃﺳﻴﺘﺎﺕ ﺍﻟﺼﻮﺩﻳﻮﻡ ﺛﻼﺛﻲ ﺍﻟﻬﻴﺪﺭﺍﺕ، ﻣﺎﺀ ﻟﻠﺤﻘﻦ.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p><strong>ﻣﺎ ﻫﻮ ﺷﻜﻞ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﻭﻣﺎ ﻫﻲ ﻣﺤﺘﻮﻳﺎﺕ ﺍﻟﻌﺒﻮﺓ</strong><br />ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﻋﺒﺎﺭﺓ ﻋﻦ ﻣﺤﻠﻮﻝ ﺻﺎﻑ ﻋﺪﱘ ﺍﻟﻠﻮﻥ.<br />ﻳﺘﻮﻓﺮ ﻋﻘﺎﺭ ﺟﻠﻴﺒﺮﻳﺴﲔ&reg; ٠٫١ ﻣﻠﻐﻢ/ ﻣﻞ ﻣﺤﻠﻮﻝ ﻟﻠﺤﻘﻦ ﻓﻲ ﻋﺒﻮﺍﺕ ﺑﻬﺎ ٥ ﺃﻣﺒﻮﻻﺕ ﺑﻜﻞ ﻣﻨﻬﺎ ٥٫٨ ﻣﻞ ﻣﻦ ﺍﶈﻠﻮﻝ.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>ﺣﺎﻣﻞ ﺣﻖ ﺍﻟﺘﺴﻮﻳﻖ: ﻓﻴﺮﻳﻨﺞ ﺟﻲ ﺍﻡ ﺑﻲ ﺍﺗﺶ، ﻭﻳﺘﻠﻨﺪ ١١، ﺩ٢٤١٠٩ &nbsp;ﻛﻴﻴﻞ، ﺃﳌﺎﻧﻴا</strong></p><p><strong>ﳌﺼﻨﻊ: ﺯﻳﻨﺘﻴﻔﺎ ﻛﻲ. ﺍﺱ.، ﻳﻮ ﻛﺎﺑﻴﻠﻔﻮﻧﻲ ٠٣١،١٠٢٣٧ &nbsp;ﺑﺮﺍﻍ، &nbsp;ﺍﳉﻤﻬﻮﺭﻳﺔ ﺍﻟﺘﺸﻴﻜﻴﺔ</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
             ﺇﺑﺮﻳﻞ٢٠١٥ .
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                GLYPRESSIN® 1mg/8.5ml Solution for
Injection
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active ingredient: 1 ampoule with 8.5 ml solution contains terlipressin
acetate equivalent to 0.1 mg terlipressin/ml.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection. Clear, colourless solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Bleeding oesophageal varices.<br />The administration of terlipressin is for emergency treatment in cases<br />of acute bleeding from oesophageal varices until endoscopic therapy<br />is available. Afterwards, administration of terlipressin for the treatment<br />of bleeding from oesophageal varices is usually an adjuvant therapy to<br />the endoscopic stopping of bleeding. Terlipressin can also be used for<br />reducing early secondary bleeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Unless otherwise prescribed, initially 1‑2 ampoule of GLYPRESSIN&reg;<br />1mg/8.5ml Solution for Injection (0.85 to 1.7 mg terlipressin) are<br />administered intravenously in adults. The maintenance dose is 1 ampoule of<br />GLYPRESSIN&reg; 1mg/8.5ml Solution for Injection after 4‑6 hours. To adapt to<br />the course of disease, the duration of treatment is to be reduced to 2‑3 days.<br />The standard value for the maximum daily dose of GLYPRESSIN&reg;<br />1mg/8.5ml Solution for Injection is 6 x 17 &mu;g/kg body weight. For an<br />adult person of 70 kg body weight, this corresponds to a dose of 8 to<br />9 ampoules (6.8‑7.65 mg) per day, to be administered in 4‑hour intervals.<br />Method of administration<br />GLYPRESSIN&reg; 1mg/8.5ml Solution for Injection is slowly administered<br />intravenously. The duration of administration is 2‑3 days.<br />Elderly patients:<br />GLYPRESSIN&reg; 1mg/8.5ml Solution for Injection should be used with<br />caution in patients over 70 years of age.<br />Paediatric population:<br />GLYPRESSIN&reg; 1mg/8.5ml Solution for Injection is not recommended in children<br />and adolescents due to insufficient experience on safety and efficacy.<br />Renal insufficiency:<br />GLYPRESSIN&reg; 1mg/8.5ml Solution for Injection should only be used with<br />caution in patients with chronic renal failure.<br />Hepatic insufficiency:<br />A dose adjustment is not required in patients with liver failure.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                - Hypersensitivity to the active ingredient or any of the other ingredients
- Pregnancy
- Septic shock in patients with low cardiac output
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>shock in patients with low cardiac output.<br />-&nbsp;&nbsp; &nbsp;Pregnancy.<br />Special Warnings and Precautions for Use<br />GLYPRESSIN&reg; 1mg/8.5ml Solution for Injection should be used with<br />caution and under close monitoring in case of the following concomitant<br />diseases:<br />-&nbsp;&nbsp; &nbsp;Septic shock;<br />-&nbsp;&nbsp; &nbsp;Bronchial asthma;<br />-&nbsp;&nbsp; &nbsp;Respiratory deficiencies;<br />-&nbsp;&nbsp; &nbsp;Uncontrolled hypertension;<br />-&nbsp;&nbsp; &nbsp;Cerebral, coronary or peripheral vascular diseases (e.g. advanced<br />arteriosclerosis);<br />-&nbsp;&nbsp; &nbsp;Pre-existing seizures (convulsions);<br />-&nbsp;&nbsp; &nbsp;Cardiac arrhythmias;<br />-&nbsp;&nbsp; &nbsp;Cardiac diseases;<br />-&nbsp;&nbsp; &nbsp;Coronary insufficiency or previous myocardial infarction;<br />-&nbsp;&nbsp; &nbsp;Chronic renal insufficiency,<br />-&nbsp;&nbsp; &nbsp;Elderly patients over 70 years of age as experience is limited in this<br />group.<br />Hypovolaemic patients also often show increased vasoconstriction and<br />atypical cardiac reactions.<br />Due to the low antidiuretic effect of terlipressin (only approx. 3 % of the<br />antidiuretic action of native vasopressin), attention should be drawn to<br />possible hyponatraemia and hypokalaemia, especially in patients with<br />already disturbed electrolyte balance.<br />During treatment blood pressure, heart rate and ECG/EKG as well as<br />fluid balance should be observed.<br />GLYPRESSIN&reg; 1mg/8.5ml Solution for Injection is only to be used under<br />continuous monitoring of the cardiovascular function using intensive<br />medical units.<br />In case of emergency requiring immediate treatment before hospitalization,<br />special attention is to be drawn to volume deficiency syndromes.<br />GLYPRESSIN&reg; 1mg/8.5ml Solution for Injection has no effect on arterial<br />bleeding.<br />To avoid local necrosis at the injection site, an intravenous injection should<br />be administered.<br />Skin Necrosis<br />During post-marketing experience several cases of cutaneous ischemia<br />and necrosis unrelated to the injection site have been reported. Patients<br />with peripheral venous hypertension or morbid obesity seem to have a<br />greater tendency to this reaction. Therefore, extreme caution should be<br />exercised when administering terlipressin in these patients.<br />Torsade de pointes<br />During clinical trials and post-marketing experience, several cases of QT<br />interval prolongation and ventricular arrhythmias including &ldquo;Torsade de<br />pointes&rdquo; have been reported. In most cases, patients had predisposing<br />factors such as basal prolongation of the QT interval, electrolyte<br />abnormalities (hypokalemia, hypomagnesemia) or medications with<br />concomitant effect on QT prolongation. Therefore, extreme caution should<br />be exercised in the use of terlipressin in patients with a history of QT<br />interval prolongation, electrolytic anormalities, concomitant medications<br />that can prolong the QT interval, such as class IA and III antiarrhythmics,<br />erythromycin, certain antihistamines and tricyclic antidepressants or<br />medications that can cause hypokalaemia or hypomagnesemia (e.g.<br />some diuretics).<br />Special Populations<br />Elderly: There is only limited experience in the treatment of elderly;<br />therefore, terlipressin should only be used in this population with special<br />care. There are no dose recommendations for elderly.<br />Due to lack of data and experience, GLYPRESSIN&reg; 1mg/8.5ml Solution<br />for Injection should not be used in children and adolescents.<br />8.5 ml of GLYPRESSIN&reg; 1mg/8.5ml Solution for Injection contain<br />1.34 mmol (30.71 mg) sodium. This should be considered in patients<br />receiving sodium-controlled diet (low sodium/low salt).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Terlipressin increases the hypotensive effect of non-selective &beta;-blockers on the portal vein. The<br />reduction in heart rate and cardiac output caused by the treatment can be attributed to the inhibition<br />of the reflexogenic activity of the heart through the vagus nerve as a result of increased blood<br />pressure. Concomitant treatment with drugs known to induce bradycardia (e.g. propofol, sufentanil)<br />can cause severe bradycardia. Terlipressin can trigger ventricular arrhythmias including &ldquo;Torsade de<br />pointes&rdquo;. Therefore, extreme caution should be exercised in the use of terlipressin in patients with<br />concomitant medications that can prolong the QT interval, such as class IA and III antiarrhythmics,<br />erythromycin, certain antihistamines and tricyclic antidepressants or medications that may cause<br />hypokalaemia or hypomagnesemia (e.g. some diuretics).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>GLYPRESSIN fails under X of pregnancy categories<br />Pregnancy: GLYPRESSIN is contraindicated during pregnancy.<br />GLYPRESSIN causes uterine contractions and increased intrauterine pressure during early pregnancy<br />and may reduce uterine blood flow. GLYPRESSIN may have a harmful effect on pregnancy and the<br />health of the foetus. Rabbits showed spontaneous abortions and malformations following treatment<br />with GLYPRESSIN.<br />Lactation: It is not known whether terlipressin passes into breast milk. The excretion of terlipressin in<br />milk has not been studied in animals. A risk to the suckling child cannot be excluded. A decision on<br />whether to continue/discontinue breast-feeding or to continue/discontinue therapy with terlipressin<br />should be made taking into account the benefit of breast-feeding to the child and the benefit of<br />terlipressin therapy to the woman.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on ability to drive and use<br />machines have been performed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most commonly reported undesirable effects in clinical trials<br />(frequency 1‑10 %) are paleness, increased blood pressure, abdominal<br />pain, nausea, diarrhoea and headache.<br />The antidiuretic effect of terlipressin may cause hyponatraemia unless<br />the fluid balance is controlled.<br />Metabolism and nutrition disorders<br />Common (&gt;1/100 to &lt;1/10): hyponatraemia<br />Nervous system disorders<br />Common (&gt;1/100 to &lt;1/10): headache.<br />Uncommon (&gt;1/1,000 to &lt;1/100): causing of seizure disorders.<br />Very rare (&lt;1/10,000): apoplexy.<br />Cardiac disorders<br />Common (&gt;1/100 to &lt;1/10): bradycardia, ventricular and supraventricular<br />arrhythmia, signs of ischaemia in ECG/EKG.<br />Uncommon (&gt;1/1,000 to &lt;1/100): acute hypertension rise, in particular<br />in patients already suffering from hypertension (generally, it decreases<br />spontaneously), tachycardia, atrial fibrillation, ventricular extrasystoles,<br />angina pectoris, myocardial infarction, overload of liquid with pulmonary<br />oedema, torsade de pointes, cardiac insufficiency.<br />Very rare (&lt;1/10,000): myocardial ischemia.</p><p>Vascular disorders<br />Common (&gt;1/100 to &lt;1/10): peripheral vasoconstriction, peripheral<br />ischaemia, hypertension, pallor of skin, hypotension.<br />Uncommon (&gt;1/1,000 to &lt;1/100): intestinal ischaemia, peripheral cyanosis,<br />hot flushes.<br />Respiratory, thoracic and mediastinal disorders<br />Uncommon (&gt;1/1,000 to &lt;1/100): difficulty in breathing, painful breathing,<br />pain in the chest (thoracic pain), bronchial spasm, respiratory insufficiency,<br />cessation of breathing.<br />Rare (&gt;1/10,000 to &lt;1/1,000): dyspnea.<br />Gastrointestinal disorders<br />Common (&gt;1/100 to &lt;1/10): spasmodic abdominal pain, nausea, diarrhea.<br />Uncommon (&gt;1/1,000 to &lt;1/100): vomiting.<br />Skin and subcutaneous tissue disorders<br />Common (&gt;1/100 to &lt;1/10): paleness.<br />Uncommon (&gt;1/1,000 to &lt;1/100): lymphangitis, skin necrosis.<br />Pregnancy, puerperium and perinatal conditions<br />Uncommon (&gt;1/1,000 to &lt;1/100): Uterine hypertonus, uterine ischemia.<br />General disorders and administration site conditions<br />Uncommon (&gt;1/1,000 to &lt;1/100): necrosis at injection site.<br />Reproductive system and breast disorders<br />Common (&gt;1/100 to &lt;1/10): spasmodic pain in the lower abdomen (in<br />women).<br />During post-marketing experience, several cases of QT interval<br />prolongation and ventricular arrhythmias including &ldquo;Torsade de pointes&rdquo;<br />have been reported and several cases of cutaneous ischemia and necrosis<br />unrelated to the injection site have been reported.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The recommended does should not be exceeded as the risk of severe circulatory disorders increases<br />with the dose. Increased blood pressure in patients with known hypertension can be controlled with<br />150 &mu;g clonidine i.v.. Bradycardia requiring therapy should be treated with atropine.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: systemic hormonal preparations, posterior<br />pituitary hormones, vasopressin and analogues. ATC code: H01BA04.<br />Terlipressin possesses little pharmacological activity, however, it is<br />metabolized into the active lysine vasopressin by enzymatic hydrolysis.<br />Doses of 0.85 mg and 1.7 mg lower the portal pressure and cause marked<br />vasoconstriction. The lowering of the portal pressure and the reduction<br />in the blood flow of the azygous vein are dose-dependent. The effect of<br />the lower dose decreased after 3 hours, while haemodynamic data show<br />that terlipressin 1.7 mg is more effective than 0.85 mg as the higher dose<br />has a more reliable effect over the entire period of treatment (4 hours).<br />Terlipressin reduces the portal hypertension, simultaneously reducing<br />the circulation in the portal vascular zone and contracting the unstriated<br />oesophageal muscles under consecutive compression of the oesophageal<br />varices.<br />The bioactive lysine vasopressin (LVP) is released protracted from the<br />inactive hormonogen terlipressin and remains in a concentration range<br />above the minimum effective and below the toxic concentration over a<br />period of 4 - 6 hours due to the metabolic elimination of the LVP that is<br />in parallel to the release. The specific actions of terlipressin are to be<br />evaluated as follows:<br />Gastrointestinal system<br />Terlipressin increases the tonus of vasal and extravasal unstriated muscle<br />cells. Due to the increased resistance of the terminal arterial vessels,<br />there is a decreased circulation of the splanchnic nerve. Reduction of the<br />arterial flow leads to a pressure decrease in the portal circulation. The<br />simultaneous contraction of the intestinal muscles leads to an increased<br />peristalsis. Furthermore, it could be shown that the muscles of the<br />oesophageal wall are contracting and thus &ldquo;ligate&rdquo; varices experimentally<br />created.<br /><strong>Kidney</strong><br />Terlipressin has only 3 % of the antidiuretic action of native vasopressin.<br />This reactivity is not clinically relevant. Renal circulation is not significantly<br />changed in normovolaemic condition. In hypovolaemic condition, renal<br />circulation is increased.<br />Blood pressure<br />The use of terlipressin has a slow haemodynamic effect over 2 - 4 hours.<br />The blood pressure is slightly increased systolically and diastolically. In<br />case of renal hypertonia and general vascular sclerosis, stronger blood<br />pressure increases were observed.<br /><strong>Heart</strong><br />No cardiotoxic effects, even with the highest dosage, have been<br />determined under terlipressin. Influences on the heart, such as<br />bradycardia, arrhythmia, coronary insufficiency, occur possibly because<br />of reflex or direct vascular constrictive effects of terlipressin.<br /><strong>Uterus</strong><br />Under terlipressin, blood circulation of the myometrium and endometrium<br />is strongly decreased.<br /><strong>Skin</strong><br />Due to its vasoconstricting effect, terlipressin leads to an insufficient<br />blood circulation of the skin. All authors report a clearly visible paleness<br />of body and skin in their patients.<br />The haemodynamic effect and the effect on the unstriated muscle cells<br />are the main factors in the pharmacology of terlipressin. The centralizing<br />effect in hypovolaemic condition is a desired side effect in patients with<br />bleeding oesophageal varices.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The mean plasma half life of terlipressin is 24 &plusmn; 2 minutes. After an i.v.<br />bolus injection, terlipressin is eliminated according to a 2nd order kinetics. For the distribution phase<br />(up to 40 minutes), a plasma half life of 12 minutes has been determined. By setting free singular restglycyl,<br />the hormone lysine-vasopressine is slowly released and reaches its peak concentration after<br />120 minutes. Only 1 % of the injected terlipressin can be detected in the urine. This indicates a nearly<br />complete degradation by endo- and exo-peptidases of the liver and the kidney.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>N/A</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium chloride, acetic acid 99 %, sodium acetate 3 H2O, water for<br />injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Incompatibilities are unknown at present</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                See outer carton.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in refrigerator (2 &deg;C &ndash; 8 &deg;C). Keep ampoules in the outer carton, in<br />order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Colorless glass ampoule.<br />Pack size: OP with 5 ampoules with 8.5 ml solution each</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste material should be disposed of in accordance<br />with national requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                FERRING GmbH. Wittland 11, D-24109 Kiel, Germany.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                April 2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>